Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ixabepilone PK in Advanced Cancer
NCT00309049Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Apr 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ixabepilone in cancer (3 arms), sponsored by R-Pharm. Primary endpoint: Pharmacokinetics of Oral Ixabepilone. Started Apr 2006; status: completed.
02
Drugs
ixabepilone
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00309049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309049.